Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Trial Profile

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 May 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Heart disorders
  • Focus Therapeutic Use
  • Acronyms PREVENT
  • Most Recent Events

    • 06 Mar 2023 Results from nested case-control study , Using data from NCT01988571; comparing breast/lymphoma patients that experienced CTRCD to breast/lymphoma patients matched on age, race, and ANTH dose without CTRCD (controls). presented at the 72nd Annual Scientific Session of the American College of Cardiology together with the World Heart Federation
    • 07 Nov 2022 Results of secondary analysis; evaluating how socioeconomic status or in terms of social determinants of health, economic stability, serve as a protective factor regarding LVEF decline during treatment with doxorubicin for breast cancer and lymphoma, presented at the American Heart Association Scientific Sessions 2022
    • 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top